We specialize in medical devices,
pharmaceuticals, and gene therapeutics targeting the global market.

We conduct continuous research and development to launch various products aimed at improving the health of patients.

Samyang Holdings achieved continuous development of innovative products in the medical device and pharmaceutical areas.

Main products include bioabsorbable surgical suture and cytotoxic anticancer drugs (solid cancer, blood cancer, etc.) These products have gained the attention of customers and have been well received in the market.

By expanding our existing business and reorganizing our portfolio for new drug development, we are well on our way to become the healthcare value creator who improves the quality of life for patients.

We are dedicated to continuous research to achieve the best level of expertise.

We have numerous patents across various fields of pharmaceutical development, including discovery of novel compounds and drug delivery systems, polymer synthesis, manufacturing process, and applications. Through applications of these proprietary technologies, we are putting in our utmost effort in developing medical devices, incrementally modified drugs and gene therapeutics.